Vanda Pharmaceuticals buy StockNews.com
Start price
29.07.23
/
50%
€5.25
Target price
29.07.24
-
Performance (%)
4.76%
End price
30.07.24
€5.50
Summary
This prediction ended on 30.07.24 with a price of €5.50. With a performance of 4.76%, the BUY prediction by StockNews_com for Vanda Pharmaceuticals closed with a slight gain. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vanda Pharmaceuticals | -5.492% | -5.492% | 21.978% | -17.009% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% | 62.272% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% | 85.454% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% | 76.580% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% | 68.715% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten